Virtu Financial LLC Glycomimetics Inc Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$1.13 - $2.54 $38,780 - $87,170	34,319 New	34,319 $81,000
Q4 2021 Feb 17, 2022	SELL	$1.44 - $2.14 $77,971 - $115,874	-54,147 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.8 - $2.39 $97,464 - $129,411	54,147 New	54,147 $119,000
Q1 2021 May 19, 2021	SELL	$2.89 - $4.22 $37,067 - $54,125	-12,826 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$2.69 - $4.24 $34,501 - $54,382	12,826 New	12,826 $48,000

Q1 2018 May 14, 2018	SELL	$16.06 - $25.35 $200,525 - $316,520	-12,486 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$10.51 - $17.22 $131,227 - $215,008	12,486	12,486 $210,000

36.8M

969K

636K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $14.7M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.